These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 1309376
21. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Christie PE, Tagari P, Ford-Hutchinson AW, Black C, Markendorf A, Schmitz-Schumann M, Lee TH. Am Rev Respir Dis; 1992 Dec; 146(6):1531-4. PubMed ID: 1333741 [Abstract] [Full Text] [Related]
23. On the role of PGD2 metabolites as markers of mast cell activation in asthma. O'Sullivan S. Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758 [Abstract] [Full Text] [Related]
24. Differential effects of leukotrienes C4, D4, and E4 in the pulmonary and systemic vasculature of sheep. Ahmed T, Marchette B, Wasserman M, Wanner A, Yerger L. Bull Eur Physiopathol Respir; 1986 Apr; 22(6):573-80. PubMed ID: 3030470 [Abstract] [Full Text] [Related]
25. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Dahlén SE, Hansson G, Hedqvist P, Björck T, Granström E, Dahlén B. Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1712-6. PubMed ID: 6300870 [Abstract] [Full Text] [Related]
26. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Frelinger AL, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD. Circulation; 2006 Jun 27; 113(25):2888-96. PubMed ID: 16785341 [Abstract] [Full Text] [Related]
27. Lipoxygenase pathway and hydroperoxy acids: possible relevance to aspirin-induced asthma and hyperirritability of airways in asthmatics. Chand N, Altura BM. Prostaglandins Med; 1981 Feb 27; 6(2):249-56. PubMed ID: 6113615 [Abstract] [Full Text] [Related]
28. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Drazen JM, O'Brien J, Sparrow D, Weiss ST, Martins MA, Israel E, Fanta CH. Am Rev Respir Dis; 1992 Jul 27; 146(1):104-8. PubMed ID: 1320817 [Abstract] [Full Text] [Related]
29. Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Westcott JY, Smith HR, Wenzel SE, Larsen GL, Thomas RB, Felsien D, Voelkel NF. Am Rev Respir Dis; 1991 Jun 27; 143(6):1322-8. PubMed ID: 1646581 [Abstract] [Full Text] [Related]
30. Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinson AW, Tagari P. Circulation; 1992 Jan 27; 85(1):230-6. PubMed ID: 1309444 [Abstract] [Full Text] [Related]
31. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. J Allergy Clin Immunol; 1992 Oct 27; 90(4 Pt 1):636-45. PubMed ID: 1328344 [Abstract] [Full Text] [Related]
32. BIO-Fully Automated Sample Treatment high-performance liquid chromatography and radioimmunoassay for leukotriene E4 in human urine from asthmatics. Nicoll-Griffith D, Zamboni R, Rasmussen JB, Ethier D, Charleson S, Tagari P. J Chromatogr; 1990 Apr 06; 526(2):341-54. PubMed ID: 2163406 [Abstract] [Full Text] [Related]
33. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Bernard GR, Korley V, Chee P, Swindell B, Ford-Hutchinson AW, Tagari P. Am Rev Respir Dis; 1991 Aug 06; 144(2):263-7. PubMed ID: 1650152 [Abstract] [Full Text] [Related]
34. Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Oosaki R, Mizushima Y, Mita H, Shida T, Akiyama K, Kobayashi M. Allergy; 1997 Apr 06; 52(4):470-3. PubMed ID: 9188934 [Abstract] [Full Text] [Related]
35. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Nasser SM, Bell GS, Foster S, Spruce KE, MacMillan R, Williams AJ, Lee TH, Arm JP. Thorax; 1994 Aug 06; 49(8):749-56. PubMed ID: 8091318 [Abstract] [Full Text] [Related]
36. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD. J Allergy Clin Immunol; 1999 Sep 06; 104(3 Pt 1):559-64. PubMed ID: 10482828 [Abstract] [Full Text] [Related]
37. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Christie PE, Smith CM, Lee TH. Am Rev Respir Dis; 1991 Oct 06; 144(4):957-8. PubMed ID: 1928974 [Abstract] [Full Text] [Related]
38. Increased production of cysteinyl leukotrienes in hepatorenal syndrome. Moore KP, Taylor GW, Maltby NH, Siegers D, Fuller RW, Dollery CT, Williams R. J Hepatol; 1990 Sep 06; 11(2):263-71. PubMed ID: 2174935 [Abstract] [Full Text] [Related]
39. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. Manso G, Baker AJ, Taylor IK, Fuller RW. Eur Respir J; 1992 Jun 06; 5(6):712-6. PubMed ID: 1321056 [Abstract] [Full Text] [Related]
40. Mediator assays in aspirin-induced asthma. Szczeklik A. Allergy Proc; 1994 Jun 06; 15(3):135-8. PubMed ID: 7926712 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]